Madison Greg 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed Aug 1, 2017
Insider Transaction Report
Form 4
Madison Greg
DirectorPresident and CEO
Transactions
- Sale
Common Stock
[F1][F2]2017-07-31$7.14/sh−4,131$29,495→ 373,637 total
Footnotes (2)
- [F1]Sale of a total of 4,131 shares of common stock was made in order to satisfy Mr. Madison's income tax withholding obligation upon the vesting of 12,813 shares of restricted stock on July 28, 2017. Mr. Madison had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- [F2]Includes 232,518 shares of restricted stock.
Signature
/s/ Brian Adams, Attorney-in-Fact|2017-08-01